dexibuprofen Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG PubChem repoDB

Active Ingredient History

NOW
  • Now
Dexibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). It is the active dextrorotatory enantiomer of ibuprofen. Most ibuprofen formulations contain a racemic mixture of both isomers.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

dexibuprofen | d-ibuproten | neoprofen | rufen | seractil | s-ibuprofen | (+)-(s)-p-isobutylhydratropic acid | (s)-α-methyl-4-(2-methylpropyl)benzeneacetic acid

Organizations (17)

Research & Development (17)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (1)


 

Pain

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Acute Pain (Phase 2)

Analgesia ()

Dysmenorrhea (Phase 4)

Fever (Phase 3)

General Surgery (Phase 4)

Healthy Volunteers (Phase 1)

Low Back Pain (Phase 4)

Migraine Disorders (Phase 4)

Osteoarthritis (Phase 4)

Pain (Phase 4)

Pain, Postoperative (Phase 4)

Respiratory Tract Infections (Phase 3)

Sprains and Strains (Phase 2)

Supratentorial Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial Organizations: 17

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue